Aripiprazole LA-Amisulpride

From Psychiatrienet
Revision as of 16:45, 16 March 2015 by Walter (talk | contribs) (Created page with '{{Drugswitch | from = Aripiprazole LA | to = Amisulpride | stop = {{Lastinjection}} | start = {{Startslweeks}} | info = {{caveQT}} | view = StopDepotStartOral.jpg')
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

{{Drugswitch | from = Aripiprazole LA | to = Amisulpride | stop =

  • Day 1: Last depot injection

| start =

  • Week 1-3: approx. 25% of target dose
  • Week 4-6: approx. 50% of target dose
  • Week 7-9: approx. 75% of target dose
  • Week 10: target dose

| info =

  • During this switch you could monitor ECG, especially in patients prone to QT-conduction problems.
  • There is a possibility of QT interval prolongation.[1]

| view = StopDepotStartOral.jpg

  1. Stöllberger C, Huber JO, Finsterer J, Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.